I. Aifantis, E. Raetz, and S. Buonamici, Molecular pathogenesis of Tcell leukaemia and lymphoma, Nat Rev Immunol, vol.8, pp.380-90, 2008.

P. Van-vlierberghe and A. Ferrando, The molecular basis of T cell acute lymphoblastic leukemia, J Clin Investig, vol.122, pp.3398-406, 2012.

T. Girardi, C. Vicente, J. Cools, D. Keersmaecker, and K. , The genetics and molecular biology of T-ALL, Blood, vol.129, pp.1113-1136, 2017.

A. H. Goldstone, S. M. Richards, H. M. Lazarus, M. S. Tallman, G. Buck et al., In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993), Blood, vol.111, pp.1827-1860, 2008.

N. Gökbuget, M. Kneba, T. Raff, H. Trautmann, C. Bartram et al., Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies, Blood, vol.120, pp.1868-76, 2012.

A. Trinquand, A. Tanguy-schmidt, B. Abdelali, R. Lambert, J. Beldjord et al., Toward a NOTCH1/FBXW7/RAS/ PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study, J Clin Oncol, vol.31, pp.4333-4375, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00979452

D. I. Marks and C. Rowntree, Management of adults with T-cell lymphoblastic leukemia, Blood, vol.129, pp.1134-1176, 2017.

K. Beldjord, S. Chevret, V. Asnafi, F. Huguet, M. Boulland et al., Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia, Blood, vol.123, pp.3739-3788, 2014.

N. Gökbuget, D. Stanze, J. Beck, H. Diedrich, H. Horst et al., Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation, Blood, vol.120, pp.2032-2073, 2012.

A. Desjonquères, P. Chevallier, X. Thomas, F. Huguet, T. Leguay et al., Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study, Blood Cancer J, vol.6, p.504, 2016.

S. Breit, M. Stanulla, T. Flohr, M. Schrappe, W. Ludwig et al., Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia, Blood, vol.108, pp.1151-1158, 2006.

V. Asnafi, A. Buzyn, L. Noir, S. Baleydier, F. Simon et al., NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study, Blood, vol.113, pp.3918-3942, 2009.

C. Pui, W. L. Carroll, S. Meshinchi, and R. J. Arceci, Biology, risk stratification, and therapy of pediatric acute leukemias: an update, J Clin Oncol, vol.29, pp.551-65, 2011.

C. Pui, C. G. Mullighan, W. E. Evans, and M. V. Relling, Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?, Blood, vol.120, pp.1165-74, 2012.

N. Dhédin, A. Huynh, S. Maury, R. Tabrizi, K. Beldjord et al., Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, vol.125, pp.2486-96, 2015.

S. K. Durum, S. Candèias, H. Nakajima, W. J. Leonard, A. M. Baird et al., Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility, J Exp Med, vol.188, pp.2233-2274, 1998.
URL : https://hal.archives-ouvertes.fr/hal-01949093

R. Mazzucchelli and S. K. Durum, Interleukin-7 receptor expression: intelligent design, Nat Rev Immunol, vol.7, pp.144-54, 2007.

A. Boudil, I. R. Matei, H. Shih, G. Bogdanoski, J. S. Yuan et al., IL-7 coordinates proliferation, differentiation and TCRA recombination during thymocyte ?-selection, Nat Immunol, vol.16, pp.397-405, 2015.

N. Tal, C. Shochat, I. Geron, D. Bercovich, and S. Izraeli, Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia, Cell Mol Life Sci, vol.71, pp.365-78, 2014.

K. De-keersmaecker, Z. K. Atak, N. Li, C. Vicente, S. Patchett et al., Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia, Nat Genet, vol.45, pp.186-90, 2013.

M. Neumann, S. Vosberg, C. Schlee, S. Heesch, S. Schwartz et al., Mutational spectrum of adult T-ALL. Oncotarget, vol.6, pp.2754-66, 2015.

C. Vicente, C. Schwab, M. Broux, E. Geerdens, S. Degryse et al., Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia, Haematologica, vol.100, pp.1301-1311, 2015.

V. Gianfelici, S. Chiaretti, S. Demeyer, D. Giacomo, F. Messina et al., RNA sequencing unravels the genetics of refractory/ relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications, Haematologica, vol.101, pp.941-50, 2016.

Y. Li, J. Buijs-gladdines, C. Barrett, K. Stubbs, A. P. Vroegindeweij et al., IL-7 receptor mutations and steroid resistance in pediatric T cell acute lymphoblastic leukemia: a genome sequencing study, PLoS Med, vol.13, p.1002200, 2016.

Y. Liu, J. Easton, Y. Shao, J. Maciaszek, Z. Wang et al., The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia, Nat Genet, vol.49, pp.1211-1219, 2017.

P. P. Zenatti, D. Ribeiro, W. Li, L. Zuurbier, M. C. Silva et al., Oncogenic IL7R gain-of-function mutations in childhood Tcell acute lymphoblastic leukemia, Nat Genet, vol.43, pp.932-941, 2011.

S. Degryse, C. E. De-bock, L. Cox, S. Demeyer, O. Gielen et al., JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model, Blood, vol.124, pp.3092-100, 2014.

S. L. Maude, S. Dolai, C. Delgado-martin, T. Vincent, A. Robbins et al., Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia, Blood, vol.125, pp.1759-67, 2015.

F. Huguet, T. Leguay, E. Raffoux, X. Thomas, K. Beldjord et al., Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study, J Clin Oncol, vol.27, pp.911-919, 2009.

F. Huguet, S. Chevret, T. Leguay, X. Thomas, N. Boissel et al., Intensified therapy of acute lymphoblastic leukemia in adults: report of the randomized GRAALL-2005 clinical trial, J Clin Oncol, vol.36, pp.2514-2537, 2018.

J. Bergeron, E. Clappier, I. Radford, A. Buzyn, C. Millien et al., Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs, Blood, vol.110, pp.2324-2354, 2007.

J. Bond, T. Marchand, A. Touzart, A. Cieslak, A. Trinquand et al., An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study, Haematologica, vol.101, pp.732-772, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01290420

V. Van-der-velden, G. Cazzaniga, A. Schrauder, J. Hancock, P. Bader et al., Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data, Leukemia, vol.21, pp.604-615, 2007.

D. R. Cox, Regression models and life-tables, J R Stat Soc Ser B Methodol, vol.34, pp.187-220, 1972.

P. M. Grambsch and T. M. Therneau, Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, vol.81, pp.515-541, 1994.

N. Mantel and D. P. Byar, Evaluation of response-time data involving transient states: an illustration using heart-transplant data, J Am Stat Assoc, vol.69, pp.81-87, 1974.

R. Simon and R. W. Makuch, A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias, Stat Med, vol.3, pp.35-44, 1984.

P. K. Andersen and R. D. Gill, Cox's regression model for counting processes: a large sample study, Ann Stat, vol.10, pp.1100-1120, 1982.

M. Krzywinski, J. Schein, I. Birol, J. Connors, R. Gascoyne et al., Circos: an information aesthetic for comparative genomics, Genome Res, vol.19, pp.1639-1684, 2009.

C. Shochat, N. Tal, V. Gryshkova, Y. Birger, O. R. Bandapalli et al., Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia, Blood, vol.124, pp.106-116, 2014.

E. A. Macintyre, L. Smit, J. Ritz, I. R. Kirsch, and J. L. Strominger, Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage, Blood, vol.80, pp.1511-1531, 1992.

A. Gutierrez, A. Kentsis, T. Sanda, L. Holmfeldt, S. Chen et al., The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia, Blood, vol.118, pp.4169-73, 2011.

C. S. Tremblay, F. C. Brown, M. Collett, J. Saw, S. K. Chiu et al., Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling, Leukemia, vol.30, pp.1993-2001, 2016.

M. Schrappe, M. G. Valsecchi, C. R. Bartram, A. Schrauder, R. Panzer-grümayer et al., Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study, Blood, vol.118, pp.2077-84, 2011.

D. O'connor, A. Enshaei, J. Bartram, J. Hancock, C. J. Harrison et al., Genotype-specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia, J Clin Oncol, vol.36, pp.34-43, 2018.

D. I. Marks, E. M. Paietta, A. V. Moorman, S. M. Richards, G. Buck et al., T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993), Blood, vol.114, pp.5136-5181, 2009.

U. Baak, N. Gökbuget, H. Orawa, S. Schwartz, D. Hoelzer et al., Thymic adult T-cell acute lymphoblastic leukemia stratified in standard-and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group, Leukemia, vol.22, pp.1154-60, 2008.

S. Degryse, C. E. De-bock, S. Demeyer, I. Govaerts, S. Bornschein et al., Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

V. Asnafi, K. Beldjord, E. Boulanger, B. Comba, L. Tutour et al., Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment, Blood, vol.101, pp.2693-703, 2003.

M. J. Pongers-willemse, O. J. Verhagen, G. J. Tibbe, A. J. Wijkhuijs, V. De-haas et al., Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia, vol.12, pp.2006-2020, 1998.

, Stéphane Lepretre 10 ? Patrice Chevallier 11,12 ? Thorsten Braun 13,14,15 ? Véronique Lhéritier 16 ? Sylvain Chantepie 17 ? Sébastien Maury 18 ? Martine Escoffre 19 ? Emmanuelle Tavernier 20 ? Yves Chalandon 21,22 ? Carlos Graux 23 ? Elizabeth Macintyre 1 ? Norbert Ifrah 8 ? Vahid Asnafi 1 ? Hervé, vol.8

, Hematology Adolescent and Young Adult Unit